Accession Number: | 0000899243-21-006365 |
Date: | 2021-02-10 |
Issuer: | MERRIMACK PHARMACEUTICALS INC (MACK) |
Original Submission Date: |
CROCKER GARY L
C/O MERRIMACK PHARMACEUTICALS, INC.
ONE BROADWAY 14TH FLOOR
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-02-10 | P | 3,500 | a | $7.64 | 3,500 | indirect | f3 | |
COMMON STOCK | 2021-02-11 | P | 1,604 | a | $7.98 | 5,104 | indirect | f3 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the price reported in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $7.24 to $8.16, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this form 4. |
f2 | the price reported in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this form 4 |
f3 | shares held by crocker family investments, llc, over which reporting person is the managing member. |